Usefulness of Dual-Time Point Imaging After Carbonated Water for the Fluorodeoxyglucose Positron Emission Imaging of Peritoneal Carcinomatosis in Colon Cancer
Fluorodeoxygluose (FDG) positron emission/computed tomography (PET/CT) is emerging as a useful tool for the diagnosis of peritoneal carcinomatosis (PC). In this study, we assessed whether dual-time point imaging can improve the accuracy of FDG PET/CT for the diagnosis of PC after colon rectal cancer...
Saved in:
Published in | Cancer biotherapy & radiopharmaceuticals Vol. 28; no. 1; pp. 29 - 33 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
New Rochelle, NY
Liebert
01.02.2013
Mary Ann Liebert, Inc |
Subjects | |
Online Access | Get full text |
ISSN | 1084-9785 1557-8852 1557-8852 |
DOI | 10.1089/cbr.2012.1179 |
Cover
Loading…
Abstract | Fluorodeoxygluose (FDG) positron emission/computed tomography (PET/CT) is emerging as a useful tool for the diagnosis of peritoneal carcinomatosis (PC). In this study, we assessed whether dual-time point imaging can improve the accuracy of FDG PET/CT for the diagnosis of PC after colon rectal cancer (CRC).
Thirty-nine patients with past history of CRC were evaluated. Whole-Body PET/CT scan was acquired 1 hour after tracer injection. If one or more focal areas of increased FDG uptake (standardized uptake value, SUV max>2.5) were found in the abdomen, 1 L of carbonated water was orally administered to patients and a delayed scan of the abdominal region was acquired at 2 hours. The SUV max and the mean Delta (Δ) SUV were calculated. The scintigraphic results were compared with the results of colonoscopy and histology and with the clinical follow-up.
Thirteen out of the 39 patients did not show any significant area of FDG uptake at the whole-body scan. The remaining 26 patients showed an overall number of 27 sites of focal increased uptake, showing a mean SUV max of 6.5+3.3. Late scan of the abdomen showed vanishing spots in 11 cases. Focal and increasing FDG uptake was found in 15 subjects (for an overall number of 16 sites) with SUV max of 15.6+4 and mean Δ SUV of +26.3%±7.5%. In these cases, final diagnosis was PC in 10 patients (according to cytology or histology) and dysplastic polyp in 5 cases. No significant difference in Δ SUV was found between patients with PC and those with polypoid formations.
According to our results, dual-time point imaging after carbonated water may increase the accuracy of FDG PET/CT for the imaging of PC in patients affected by CRC. |
---|---|
AbstractList | Background: Fluorodeoxygluose (FDG) positron emission/computed tomography (PET/CT) is emerging as a useful tool for the diagnosis of peritoneal carcinomatosis (PC). In this study, we assessed whether dual-time point imaging can improve the accuracy of FDG PET/CT for the diagnosis of PC after colon rectal cancer (CRC). Methods: Thirty-nine patients with past history of CRC were evaluated. Whole-Body PET/CT scan was acquired 1 hour after tracer injection. If one or more focal areas of increased FDG uptake (standardized uptake value, SUV max>2.5) were found in the abdomen, 1 L of carbonated water was orally administered to patients and a delayed scan of the abdominal region was acquired at 2 hours. The SUV max and the mean Delta (Δ) SUV were calculated. The scintigraphic results were compared with the results of colonoscopy and histology and with the clinical follow-up. Results: Thirteen out of the 39 patients did not show any significant area of FDG uptake at the whole-body scan. The remaining 26 patients showed an overall number of 27 sites of focal increased uptake, showing a mean SUV max of 6.5+3.3. Late scan of the abdomen showed vanishing spots in 11 cases. Focal and increasing FDG uptake was found in 15 subjects (for an overall number of 16 sites) with SUV max of 15.6+4 and mean Δ SUV of +26.3%±7.5%. In these cases, final diagnosis was PC in 10 patients (according to cytology or histology) and dysplastic polyp in 5 cases. No significant difference in Δ SUV was found between patients with PC and those with polypoid formations. Conclusions: According to our results, dual-time point imaging after carbonated water may increase the accuracy of FDG PET/CT for the imaging of PC in patients affected by CRC. Fluorodeoxygluose (FDG) positron emission/computed tomography (PET/CT) is emerging as a useful tool for the diagnosis of peritoneal carcinomatosis (PC). In this study, we assessed whether dual-time point imaging can improve the accuracy of FDG PET/CT for the diagnosis of PC after colon rectal cancer (CRC). Thirty-nine patients with past history of CRC were evaluated. Whole-Body PET/CT scan was acquired 1 hour after tracer injection. If one or more focal areas of increased FDG uptake (standardized uptake value, SUV max>2.5) were found in the abdomen, 1 L of carbonated water was orally administered to patients and a delayed scan of the abdominal region was acquired at 2 hours. The SUV max and the mean Delta (Δ) SUV were calculated. The scintigraphic results were compared with the results of colonoscopy and histology and with the clinical follow-up. Thirteen out of the 39 patients did not show any significant area of FDG uptake at the whole-body scan. The remaining 26 patients showed an overall number of 27 sites of focal increased uptake, showing a mean SUV max of 6.5+3.3. Late scan of the abdomen showed vanishing spots in 11 cases. Focal and increasing FDG uptake was found in 15 subjects (for an overall number of 16 sites) with SUV max of 15.6+4 and mean Δ SUV of +26.3%±7.5%. In these cases, final diagnosis was PC in 10 patients (according to cytology or histology) and dysplastic polyp in 5 cases. No significant difference in Δ SUV was found between patients with PC and those with polypoid formations. According to our results, dual-time point imaging after carbonated water may increase the accuracy of FDG PET/CT for the imaging of PC in patients affected by CRC. Fluorodeoxygluose (FDG) positron emission/computed tomography (PET/CT) is emerging as a useful tool for the diagnosis of peritoneal carcinomatosis (PC). In this study, we assessed whether dual-time point imaging can improve the accuracy of FDG PET/CT for the diagnosis of PC after colon rectal cancer (CRC).BACKGROUNDFluorodeoxygluose (FDG) positron emission/computed tomography (PET/CT) is emerging as a useful tool for the diagnosis of peritoneal carcinomatosis (PC). In this study, we assessed whether dual-time point imaging can improve the accuracy of FDG PET/CT for the diagnosis of PC after colon rectal cancer (CRC).Thirty-nine patients with past history of CRC were evaluated. Whole-Body PET/CT scan was acquired 1 hour after tracer injection. If one or more focal areas of increased FDG uptake (standardized uptake value, SUV max>2.5) were found in the abdomen, 1 L of carbonated water was orally administered to patients and a delayed scan of the abdominal region was acquired at 2 hours. The SUV max and the mean Delta (Δ) SUV were calculated. The scintigraphic results were compared with the results of colonoscopy and histology and with the clinical follow-up.METHODSThirty-nine patients with past history of CRC were evaluated. Whole-Body PET/CT scan was acquired 1 hour after tracer injection. If one or more focal areas of increased FDG uptake (standardized uptake value, SUV max>2.5) were found in the abdomen, 1 L of carbonated water was orally administered to patients and a delayed scan of the abdominal region was acquired at 2 hours. The SUV max and the mean Delta (Δ) SUV were calculated. The scintigraphic results were compared with the results of colonoscopy and histology and with the clinical follow-up.Thirteen out of the 39 patients did not show any significant area of FDG uptake at the whole-body scan. The remaining 26 patients showed an overall number of 27 sites of focal increased uptake, showing a mean SUV max of 6.5+3.3. Late scan of the abdomen showed vanishing spots in 11 cases. Focal and increasing FDG uptake was found in 15 subjects (for an overall number of 16 sites) with SUV max of 15.6+4 and mean Δ SUV of +26.3%±7.5%. In these cases, final diagnosis was PC in 10 patients (according to cytology or histology) and dysplastic polyp in 5 cases. No significant difference in Δ SUV was found between patients with PC and those with polypoid formations.RESULTSThirteen out of the 39 patients did not show any significant area of FDG uptake at the whole-body scan. The remaining 26 patients showed an overall number of 27 sites of focal increased uptake, showing a mean SUV max of 6.5+3.3. Late scan of the abdomen showed vanishing spots in 11 cases. Focal and increasing FDG uptake was found in 15 subjects (for an overall number of 16 sites) with SUV max of 15.6+4 and mean Δ SUV of +26.3%±7.5%. In these cases, final diagnosis was PC in 10 patients (according to cytology or histology) and dysplastic polyp in 5 cases. No significant difference in Δ SUV was found between patients with PC and those with polypoid formations.According to our results, dual-time point imaging after carbonated water may increase the accuracy of FDG PET/CT for the imaging of PC in patients affected by CRC.CONCLUSIONSAccording to our results, dual-time point imaging after carbonated water may increase the accuracy of FDG PET/CT for the imaging of PC in patients affected by CRC. |
Author | Scopinaro, Francesco D'Arienzo, Marco Bagni, Oreste Filippi, Luca Salvatori, Rita |
Author_xml | – sequence: 1 givenname: Luca surname: Filippi fullname: Filippi, Luca organization: Section of Nuclear Medicine, Santa Maria Goretti Hospital, Latina, Italy – sequence: 2 givenname: Marco surname: D'Arienzo fullname: D'Arienzo, Marco organization: ENEA, National Institute of Ionizing Radiation Metrology, Rome, Italy – sequence: 3 givenname: Francesco surname: Scopinaro fullname: Scopinaro, Francesco organization: Section of Nuclear Medicine, Sant'Andrea Hospital, Rome, Italy – sequence: 4 givenname: Rita surname: Salvatori fullname: Salvatori, Rita organization: Section of Nuclear Medicine, Santa Maria Goretti Hospital, Latina, Italy – sequence: 5 givenname: Oreste surname: Bagni fullname: Bagni, Oreste organization: Section of Nuclear Medicine, Santa Maria Goretti Hospital, Latina, Italy |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27090714$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/23134220$$D View this record in MEDLINE/PubMed |
BookMark | eNptkk9rHSEUxYeS0vxpl90WoRS6mVevzjx1GaZJGwg0i4QuxXH01eBoqg4kX6aftQ55j0Loyov-zrn3yjltjkIMpmneA94A5uKLHtOGYCAbACZeNSfQ96zlvCdHtca8awXj_XFzmvM9xniLt-xNc0wo0I4QfNL8ucvGLj6YnFG06OuifHvrZoNuogsFXc1q58IOndtiEhpUGmNQxUzop1ovbEyo_DLo0i8xxcnEx6edX3TMqz67kmJAF7PL2dXi4FXb3JjkSt1D-dVTuxBnVaogIxfQEH2lBxW0SW-b11b5bN7tz7Pm7vLidvjeXv_4djWcX7ea9lBavR2pAEYIaGY6GPmkOo5p35ERCBbEMjVpLihYsEJgzjo8gbCAle4pmzA9az4_-z6k-Hsxucg6tTbeq2DikiUQRikHuiUV_fgCvY9LCnU6Wd-3tO9ro0p92FPLOJtJPiQ3q_QkDz9fgU97QGWtvE11X5f_cQwLzKCrHH3mdIo5J2OldkWV-qElKeclYLnmQNYcyDUHcs1BVbUvVAfj__N_AXEUtFA |
CODEN | CBRAFJ |
CitedBy_id | crossref_primary_10_1007_s40336_022_00534_4 crossref_primary_10_1007_s41365_017_0294_8 crossref_primary_10_1016_j_nucmedbio_2014_08_011 crossref_primary_10_1089_cbr_2014_1612 crossref_primary_10_1007_s00261_015_0418_8 |
Cites_doi | 10.1097/01.RLU.0000067510.43457.52 10.1097/PAS.0b013e318205df36 10.1111/j.1749-6632.2011.06077.x 10.1016/S1095-0397(99)00016-3 10.1007/s00330-009-1527-y 10.2967/jnumed.108.057307 10.1089/108497804773391621 10.2214/AJR.09.2936 10.1016/S0016-5085(99)70278-7 10.1055/s-1999-270 10.1016/S0016-5085(97)70119-7 10.1097/00003072-199802000-00008 10.1097/00042737-200209000-00010 10.1055/s-0038-1625195 |
ContentType | Journal Article |
Copyright | 2014 INIST-CNRS (©) Copyright 2013, Mary Ann Liebert, Inc. |
Copyright_xml | – notice: 2014 INIST-CNRS – notice: (©) Copyright 2013, Mary Ann Liebert, Inc. |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7QP 7T5 7TK 7X7 7XB 88A 88E 88I 8C1 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M2P M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 |
DOI | 10.1089/cbr.2012.1179 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Immunology Abstracts Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) Public Health Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea ProQuest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni) PML(ProQuest Medical Library) Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest Central Student MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1557-8852 |
EndPage | 33 |
ExternalDocumentID | 2992505691 23134220 27090714 10_1089_cbr_2012_1179 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .GJ 0R~ 29B 34G 39C 4.4 53G 5GY 5RE 6PF 7X7 88E 88I 8C1 8FE 8FH 8FI 8FJ 8WZ A6W AAWTL AAYXX ABBKN ABJNI ABUWG ACGFS ACGOD ACPRK ADBBV AENEX AFKRA AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AZQEC BBNVY BENPR BHPHI BNQNF BPHCQ BVXVI CAG CCPQU CITATION COF CS3 DU5 DWQXO EBS EJD F5P FYUFA GNUQQ HCIFZ HMCUK IAO IHR IM4 INH INR ITC L7B LK8 M1P M2P M7P O9- P2P PHGZM PHGZT PQQKQ PROAC PSQYO RIG RML RMSOB UDS UE5 UKHRP ZGI IQODW PJZUB PPXIY PQGLB CGR CUY CVF ECM EIF NPM 3V. 7QP 7T5 7TK 7XB 88A 8FK H94 K9. PKEHL PQEST PQUKI PRINS Q9U 7X8 |
ID | FETCH-LOGICAL-c351t-c6b3917221c7e41b8da4803542b12092f7adc8931f1f9908740d19f10ac537d03 |
IEDL.DBID | 7X7 |
ISSN | 1084-9785 1557-8852 |
IngestDate | Tue Aug 05 09:39:13 EDT 2025 Fri Aug 15 23:00:41 EDT 2025 Thu Apr 03 07:01:50 EDT 2025 Mon Jul 21 09:12:07 EDT 2025 Tue Jul 01 02:47:24 EDT 2025 Thu Apr 24 23:07:49 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Radionuclide study 2-deoxy-2-fluoroglucose Rectal disease carbonated water Colon cancer colon rectal cancer Peritoneal carcinomatosis Intestinal disease Diagnosis Anorectal disease Human Radiodiagnosis Fludeoxyglucose (18F) Malignant tumor Rectum cancer Carbonated beverage Colonic disease Abdominal disease PET/CT Digestive diseases Medical imagery Computerized axial tomography Positron emission tomography Cancer Emission tomography |
Language | English |
License | http://www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121 CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c351t-c6b3917221c7e41b8da4803542b12092f7adc8931f1f9908740d19f10ac537d03 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 23134220 |
PQID | 1366355893 |
PQPubID | 33066 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_1273381362 proquest_journals_1366355893 pubmed_primary_23134220 pascalfrancis_primary_27090714 crossref_citationtrail_10_1089_cbr_2012_1179 crossref_primary_10_1089_cbr_2012_1179 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2013-02-01 |
PublicationDateYYYYMMDD | 2013-02-01 |
PublicationDate_xml | – month: 02 year: 2013 text: 2013-02-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | New Rochelle, NY |
PublicationPlace_xml | – name: New Rochelle, NY – name: United States – name: New Rochelle |
PublicationTitle | Cancer biotherapy & radiopharmaceuticals |
PublicationTitleAlternate | Cancer Biother Radiopharm |
PublicationYear | 2013 |
Publisher | Liebert Mary Ann Liebert, Inc |
Publisher_xml | – name: Liebert – name: Mary Ann Liebert, Inc |
References | Suzuki A (B8) 2004; 10 B10 B11 B12 B14 B15 B16 Boudiaf M (B2) 1999; 53 B17 B18 B19 Gryspeerdt S (B3) 1998; 19 B1 B4 Turlakow A (B5) 2003; 44 B6 B7 B9 Nakamoto Y (B13); 2002 |
References_xml | – volume: 53 start-page: 115 year: 1999 ident: B2 publication-title: Ann Chir – volume: 19 start-page: 434 year: 1998 ident: B3 publication-title: Eur J Gynaecol Oncol – ident: B16 doi: 10.1097/01.RLU.0000067510.43457.52 – ident: B19 doi: 10.1097/PAS.0b013e318205df36 – ident: B7 doi: 10.1111/j.1749-6632.2011.06077.x – ident: B12 doi: 10.1016/S1095-0397(99)00016-3 – ident: B14 doi: 10.1007/s00330-009-1527-y – ident: B11 doi: 10.2967/jnumed.108.057307 – ident: B6 doi: 10.1089/108497804773391621 – ident: B9 doi: 10.2214/AJR.09.2936 – ident: B18 doi: 10.1016/S0016-5085(99)70278-7 – ident: B4 doi: 10.1055/s-1999-270 – volume: 44 start-page: 1407 year: 2003 ident: B5 publication-title: J Nucl Med – ident: B1 doi: 10.1016/S0016-5085(97)70119-7 – ident: B17 doi: 10.1097/00003072-199802000-00008 – ident: B15 doi: 10.1097/00042737-200209000-00010 – volume: 10 start-page: 1413 year: 2004 ident: B8 publication-title: Eur J Nucl Med Mol Imaging – ident: B10 doi: 10.1055/s-0038-1625195 – volume: 2002 start-page: 171 ident: B13 publication-title: Mol Imaging Biol |
SSID | ssj0006067 |
Score | 2.008002 |
Snippet | Fluorodeoxygluose (FDG) positron emission/computed tomography (PET/CT) is emerging as a useful tool for the diagnosis of peritoneal carcinomatosis (PC). In... Background: Fluorodeoxygluose (FDG) positron emission/computed tomography (PET/CT) is emerging as a useful tool for the diagnosis of peritoneal carcinomatosis... |
SourceID | proquest pubmed pascalfrancis crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 29 |
SubjectTerms | Abdomen Adult Aged Biological and medical sciences Carbonated Water - administration & dosage Colonic Neoplasms - diagnostic imaging Colonic Neoplasms - pathology Digestion. Liver. Biliary tract. Spleen. Pancreas Female Fluorodeoxyglucose F18 Gastroenterology. Liver. Pancreas. Abdomen Humans Investigative techniques, diagnostic techniques (general aspects) Male Medical sciences Middle Aged Peritoneal Neoplasms - diagnostic imaging Peritoneal Neoplasms - secondary Positron-Emission Tomography Prognosis Radionuclide investigations Radiopharmaceuticals Rectal Neoplasms - diagnostic imaging Rectal Neoplasms - pathology Time Factors Tomography, X-Ray Computed Tumors |
Title | Usefulness of Dual-Time Point Imaging After Carbonated Water for the Fluorodeoxyglucose Positron Emission Imaging of Peritoneal Carcinomatosis in Colon Cancer |
URI | https://www.ncbi.nlm.nih.gov/pubmed/23134220 https://www.proquest.com/docview/1366355893 https://www.proquest.com/docview/1273381362 |
Volume | 28 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgk3hhCAaMwKiMhPrUaP5I6uQJjdBqIG2K0Cr6FiWOLU0qSdc0Ev1n-Fu5S9xUexgvkZI4duK7-H7n-yLkM6BUpYwtfV1oUFBsIP3CMgankgkjS6U1RiNf30yvFsGPZbh0G26Nc6vcr4ndQl3WGvfIL7jsZCOI1y_rex-rRqF11ZXQeEqOMXUZunSp5aBwMQDnqnewD3zQlkKXY5NF8YUuMBkoF2i0jB_IpOfrvIHpsX1di8eBZyeA5i_JC4cc6WVP6lfkialOybNrZxs_JeO0z0K9m9DbQ1BVM6Fjmh7yU-9ek7-Lxth2hWscrS391uYrHyNBaFrfVVv6_XdXuIheYvVwmuSbAjfYTUl_5XgBQC4F0Ejnq7aGxdfUf3bO7R2eh8na1BWdAfPgLtzQFwyTAqtj4m_4hATrF1U1YGV4oKF3FU3g1eCIHLh5Qxbz2W1y5bsyDb6WId_6elpIUPqE4FqZgBdRmQcRk2EgCgzMFVblpQa6ccstyD6sAVjy2HKW61Cqksm35KiC8d8RanlkgnhqeA44TXFRhHEeK9CVQw23eOSRyZ5QmXY5zLGUxirrbOlRnAFdM6QrJjGPPTIemq_75B2PNRw9oPrQWigWY4iXR873bJC5n7zJDizpkU_DbZhhtLnklalbaAPwEEARwASPnPXsc-hcchkIwd7_v_MP5ESgRQwDOjs_mnNytN205iOgoW0x6lgejlHCR-T46-wm_fkPErELbQ |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwED-NToJJCMH4FxjDSNCnRovtpEkeEBpdq5atVYVasbcscWxpUpeUphX0y_AR-IzcJWmrPYy3vVRK49ht7nz-nc93P4CPiFJ9X5vUVolCB8W40k6M4-CldISWqa8UZSMPR-3-1P126V3uwd9NLgwdq9zYxNJQp7miPfITLsu1EZfXL_OfNrFGUXR1Q6FRqcW5Xv9Cl634PDhD-X4SoteddPp2zSpgK-nxpa3aiUQfRQiufO3yJEhjN3Ck54qE8kiF8eNU4TDccIOmmijrUh4a7sTKk37qSOz3Aey7El2ZBux_7Y7G37e2H90BvzrS79ron3l1VU8nCE9UQuVHuaAwaXhrFXw8jwsUiKmYNO6GuuWS13sKT2qsyk4r5XoGezo7hIfDOhp_CM1xVfd63WKTXRpX0WJNNt5VxF4_hz_TQpvVjKwqyw07W8Uzm3JP2Di_zpZscFNSJbFT4itnnXiR0Ja-TtmPmL5AWM0QprLebJWjudf573V90B6fR_Es8ox1UV1p32_bFw4zxslFpcbxL3SIMSnLEZ3jAwW7zlgHfxp-ks4vXsD0XkT4EhoZjv8amOGBdsO25jEiQ5-LxAvj0Efv3FN4iwcWtDaCilRdNZ3IO2ZRGb0PwgjlGpFcqWx6aEFz23xelQu5q-HxLalvWwvfCSmpzIKjjRpEtVkpot0ksODD9ja-YYryxJnOV9gGASnCMAQmFryq1GfXueTSFcJ58__O38Oj_mR4EV0MRudv4UCUDCB0gucIGsvFSr9DHLZMjmvlZ3B13_PtH1OGRDw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VIlVICEGBEihlkSCnWPHu2ln7gFCVNGoorXxoRG7GXu9KlYId4kSQP8MP4dcx40eiHsqtl0iJ17uO57Hf7LwAPiBKVcrYzNGpRgPFetJJreviV-kKIzOlNWUjX14Nzqfel5k_24O_bS4MhVW2OrFS1Fmh6Yy8z2W1N-L22rdNWEQ0Gn9e_HSogxR5Wtt2GjWLXJjNLzTfyk-TEdL6oxDjs-vhudN0GHC09PnK0YNUor0iBNfKeDwNssQLXOl7IqWcUmFVkmlckltuUW1T-7qMh5a7ifalylyJ8z6AhwonIxlTs62x56JhoOrgfs9BS81v6nu6QdjXKRUi5YIcpuGt_fDxIimRNLbuqXE36K02v_FTeNKgVnZas9kz2DP5IRxcNn75Q-hGdQXsTY9d7xK6yh7rsmhXG3vzHP5MS4MvlvQrKywbrZO5Q1koLCpu8hWb_KiaJrFT6lzOhskypcN9k7FvCf2AAJshYGXj-bpAxW-K35sm5B7vR-Isi5ydIePSCeB2LlwmQjGjouP4F4bUOykvEKfjDSW7ydkQHw0_ifuXL2B6LwR8Cfs5rv8KmOWB8cKB4QliRMVF6odJqNBO9zVe4kEHei2hYt3UT6c2HvO48uMHYYx0jYmuVEA97EB3O3xRFw65a-DJLapvRwvlhpRe1oHjlg3iRsGU8U4cOvB-exnfMPl7ktwUaxyD0BQBGUKUDhzV7LObXHLpCeG-_v_k7-AApSz-Orm6eAOPRNUKhEJ5jmF_tVybtwjIVulJxfkMvt-3qP0D6kVHDA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Usefulness+of+Dual-Time+Point+Imaging+After+Carbonated+Water+for+the+Fluorodeoxyglucose+Positron+Emission+Imaging+of+Peritoneal+Carcinomatosis+in+Colon+Cancer&rft.jtitle=Cancer+biotherapy+%26+radiopharmaceuticals&rft.au=Filippi%2C+Luca&rft.au=D%27Arienzo%2C+Marco&rft.au=Scopinaro%2C+Francesco&rft.au=Salvatori%2C+Rita&rft.date=2013-02-01&rft.issn=1084-9785&rft.eissn=1557-8852&rft.volume=28&rft.issue=1&rft.spage=29&rft.epage=33&rft_id=info:doi/10.1089%2Fcbr.2012.1179&rft.externalDBID=n%2Fa&rft.externalDocID=10_1089_cbr_2012_1179 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1084-9785&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1084-9785&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1084-9785&client=summon |